February 26, 20150Comments

PROUD Study Shows PrEP (Pre-Exposure Prophylaxis) Stops 86% of HIV Infections

A study of pre-exposure prophylaxis (PrEP), the English PROUD study, demonstrated the highest effectiveness yet seen for this method of HIV prevention, was presented at CROI 2015 in Seattle, WA

by Michelle Sherman

January 30, 20150Comments

PREZCOBIX Approved By FDA

Today the FDA approved Janssen Therapeutics combination HIV antiretroviral, PREZCOBIX which is a combination of darunavir 800mg and cobicistat 150mg. PREZCOBIX is indicated for the treatment of HIV-1 in combination with

by Michelle Sherman

January 29, 20150Comments

EVOTAZ Approved By FDA

Today the FDA approved Bristol-Myers Squibb Company’s new HIV antiretroviral combination EVOTAZ. Evotaz is a combination of atazanavir and Cobicistat and is approved for the treatment of HIV-1 infection in

by Michelle Sherman

January 23, 20150Comments

Smoking Deadly For People on HIV Treatment

AIDS researchers have found that smoking doubles the risk of death for people who are taking HIV antiretroviral medications (ARV’s). The findings of this research were published in the Journal

by Michelle Sherman

October 15, 20140Comments

Medicare Part D Open Enrollment Starts Today

Today is the day that Open Enrollment begins for Medicare Part D for 2015. The Open enrollment period runs from October 15th through December 7th 2014. If you, your partner, a

by Michelle Sherman

August 26, 20140Comments

Triumeq New HIV Single Tablet Regimen Approved By FDA

The U.S. Food and Drug Administration (FDA) has approved Triumeq, ViiV Healthcare’s single-tablet, triple-combination antiretroviral (ARV) regimen, as a first-line therapy to treat HIV. The tablet is comprised of the

by Michelle Sherman

August 18, 20140Comments

Medicare Fraud Affects Us All

It’s nothing new to see doctors and pharmacies cook up elaborate schemes to commit Medicare, Medicaid and ADAP fraud. These unscrupulous, illegal behaviors ultimately affect us all by causing increased healthcare

by Michelle Sherman

July 30, 20140Comments

HIV Positive Patients In South Africa Will be Treated Earlier

HIV Positive people in South Africa are not started on antiretroviral therapy until they have a CD4+ count of less than 350 cells/ml. According to the South African Health Minister Aaron

by Michelle Sherman

July 29, 20140Comments

New Access to HIV Care, New Difficulties in Affordability

by Heather Mack, California Healthline Contributing Reporter, California Healthline, Monday, July 28, 2014 Health care experts were counting on the Affordable Care Act to pave the way toward better treatment for

by Michelle Sherman

May 16, 20140Comments

CDC Recommends Daily Truvada (PrEP) in High Risk Adults

On May 14th the CDC and DHHS released the first Clinical Practice Guidelines for Pre Exposure Prophylaxis (PrEP) for HIV prevention in the United States. The guidelines recommend Truvada ( tenofovir/emtricitabine)

by Michelle Sherman

« Older Articles Newer Articles »